Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

BIFF F PALMER

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1053380550
CMS profile
319932
Location
DALLAS, TX

General Payments · PY2019–2025

$866,883.85

  • Reported across 874 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$28,945.38

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Bayer HealthCare Pharmaceuticals Inc. $25,250.09 19
Apellis Pharmaceuticals, Inc. $2,027.45 2
Acerta Pharma LLC $1,646.46 2
AKEBIA THERAPEUTICS INC $21.38 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $170,930.29 218
PY2020 $84,646.40 67
PY2021 $214,909.43 225
PY2022 $174,948.09 179
PY2023 $138,454.71 121
PY2024 $54,049.55 40
PY2025 $28,945.38 24

Payment records · PY2025 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $21.38 11/07/2025 Food and Beverage Undisputed 06/30/2026 1241824027 CMS
Apellis Pharmaceuticals, Inc. $27.45 05/22/2025 Food and Beverage Undisputed 06/30/2026 1253190446 CMS
Apellis Pharmaceuticals, Inc. $2,000.00 08/19/2025 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 06/30/2026 1253190448 CMS
AstraZeneca Pharmaceuticals LP $1,546.46 03/12/2025 Grant Undisputed 06/30/2026 1206641771 CMS
AstraZeneca Pharmaceuticals LP $100.00 05/26/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1207187705 CMS
Bayer Healthcare Pharmaceuticals Inc. $150.49 01/18/2025 Food and Beverage Undisputed 06/30/2026 1225682360 CMS
Bayer Healthcare Pharmaceuticals Inc. $65.65 01/18/2025 Food and Beverage Undisputed 06/30/2026 1225682362 CMS
Bayer Healthcare Pharmaceuticals Inc. $113.03 01/18/2025 Food and Beverage Undisputed 06/30/2026 1225682364 CMS
Bayer Healthcare Pharmaceuticals Inc. $121.83 06/27/2025 Food and Beverage Undisputed 06/30/2026 1225682328 CMS
Bayer Healthcare Pharmaceuticals Inc. $3,614.00 07/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1225682334 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.40 07/07/2025 Travel and Lodging Undisputed 06/30/2026 1225682340 CMS
Bayer Healthcare Pharmaceuticals Inc. $84.97 09/16/2025 Food and Beverage Undisputed 06/30/2026 1225682332 CMS
Bayer Healthcare Pharmaceuticals Inc. $3,942.00 09/22/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1225682358 CMS
Bayer Healthcare Pharmaceuticals Inc. $3,614.00 09/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1225682338 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.40 10/04/2025 Travel and Lodging Undisputed 06/30/2026 1225682336 CMS
Bayer Healthcare Pharmaceuticals Inc. $71.05 11/06/2025 Food and Beverage Undisputed 06/30/2026 1225682330 CMS
Bayer Healthcare Pharmaceuticals Inc. $233.18 11/06/2025 Travel and Lodging Undisputed 06/30/2026 1225682346 CMS
Bayer Healthcare Pharmaceuticals Inc. $256.99 11/14/2025 Travel and Lodging Undisputed 06/30/2026 1225682350 CMS
Bayer Healthcare Pharmaceuticals Inc. $6,242.00 12/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1225682356 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.00 12/19/2025 Travel and Lodging Undisputed 06/30/2026 1225682342 CMS
Bayer Healthcare Pharmaceuticals Inc. $202.58 12/19/2025 Travel and Lodging Undisputed 06/30/2026 1225682344 CMS
Bayer Healthcare Pharmaceuticals Inc. $211.52 12/19/2025 Travel and Lodging Undisputed 06/30/2026 1225682352 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.00 12/19/2025 Travel and Lodging Undisputed 06/30/2026 1225682354 CMS
Bayer Healthcare Pharmaceuticals Inc. $6,242.00 12/23/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1225682348 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.